Skip to main content
Erschienen in: Neurological Sciences 3/2011

01.06.2011 | Original Article

Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life

verfasst von: Alberto Raggi, Matilde Leonardi, Gennaro Bussone, Domenico D’Amico

Erschienen in: Neurological Sciences | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The aim of this paper is to explore the relationships between health-related quality of life (HRQoL), assessed with the Short Form-36 (SF-36), and disability in adult migraineurs using both disease-specific and generic tools, the WHO Disability Assessment Schedule II (WHO-DAS II) and with the Migraine Disability Assessment questionnaire (MIDAS). Significant differences were observed between patients with minimal/mild and moderate/severe MIDAS disability grades for Role Physical, Bodily Pain, General Health, Vitality, Social Functioning and Physical Composite Score of the SF-36; in the WHO-DAS II for household activities, participation in society and for summary score. WHO-DAS II and MIDAS provide complementary information on the intensity and the frequency of problems in performing daily activities, and could be used jointly. Our findings indicate that these issues are relevant for patients’ health status and should be taken into account in future research on migraine as important secondary outcomes of treatment interventions.
Literatur
1.
Zurück zum Zitat Freitag F (2007) The cycle of migraine: patients’ quality of life during and between migraine attacks. Clin Ther 29:939–949PubMedCrossRef Freitag F (2007) The cycle of migraine: patients’ quality of life during and between migraine attacks. Clin Ther 29:939–949PubMedCrossRef
2.
Zurück zum Zitat Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF (2003) Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 23:441–450PubMedCrossRef Lipton RB, Liberman JN, Kolodner KB, Bigal ME, Dowson A, Stewart WF (2003) Migraine headache disability and health-related quality-of-life: a population-based case-control study from England. Cephalalgia 23:441–450PubMedCrossRef
3.
Zurück zum Zitat Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210PubMedCrossRef Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210PubMedCrossRef
4.
Zurück zum Zitat Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D’Amico D (2004) Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 25:S105–S107PubMedCrossRef Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, D’Amico D (2004) Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci 25:S105–S107PubMedCrossRef
5.
Zurück zum Zitat Murray CJL, Lopez AD, Mathers CD, Stein C (2000) WHO Burden Series paper 36: The Global Burden of Disease 2000 project: aims, methods and data sources. WHO, Geneva Murray CJL, Lopez AD, Mathers CD, Stein C (2000) WHO Burden Series paper 36: The Global Burden of Disease 2000 project: aims, methods and data sources. WHO, Geneva
6.
Zurück zum Zitat World Health Organization (2001) The World Health Report 2001: Mental health, new understanding new hope. WHO, Geneva World Health Organization (2001) The World Health Report 2001: Mental health, new understanding new hope. WHO, Geneva
7.
Zurück zum Zitat Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S1–S27CrossRef Andlin-Sobocki P, Jönsson B, Wittchen HU, Olesen J (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S1–S27CrossRef
8.
Zurück zum Zitat Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S59–S62CrossRef Berg J, Stovner LJ (2005) Cost of migraine and other headaches in Europe. Eur J Neurol 12:S59–S62CrossRef
9.
Zurück zum Zitat Massetto N, Gambini C, Bernardoni P, Ferrante E, Lovati C, Moschiano F, Tonini MC, Bussone G, D’Amico D (2009) Underdiagnosis of primary headaches: results of a survey on patients attending headache centres. Neurol Sci 30:S129–S131PubMedCrossRef Massetto N, Gambini C, Bernardoni P, Ferrante E, Lovati C, Moschiano F, Tonini MC, Bussone G, D’Amico D (2009) Underdiagnosis of primary headaches: results of a survey on patients attending headache centres. Neurol Sci 30:S129–S131PubMedCrossRef
10.
Zurück zum Zitat Lipton RB, Stewart WF (1993) Migraine in the United States: a review of epidemiology and health care use. Neurology 43:6–10 Lipton RB, Stewart WF (1993) Migraine in the United States: a review of epidemiology and health care use. Neurology 43:6–10
11.
Zurück zum Zitat Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, on behalf of the AEGIS Investigator Study Group (2008) Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS trial. Headache 48:341–354PubMedCrossRef Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, on behalf of the AEGIS Investigator Study Group (2008) Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS trial. Headache 48:341–354PubMedCrossRef
12.
Zurück zum Zitat D’Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F, De Marco R, Massetto N, Bussone G, Progetto Cefalee Lombardia Group (2006) Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26:691–696PubMedCrossRef D’Amico D, Solari A, Usai S, Santoro P, Bernardoni P, Frediani F, De Marco R, Massetto N, Bussone G, Progetto Cefalee Lombardia Group (2006) Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study. Cephalalgia 26:691–696PubMedCrossRef
13.
Zurück zum Zitat Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L (2007) The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56PubMedCrossRef Dahlöf C, Loder E, Diamond M, Rupnow M, Papadopoulos G, Mao L (2007) The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56PubMedCrossRef
14.
Zurück zum Zitat Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ, Jhingran P (2000) Validity and reliability of the migraine-specific quality of life questionnaire (MSQ version 2.1). Headache 40:204–215PubMedCrossRef Martin BC, Pathak DS, Sharfman MI, Adelman JU, Taylor F, Kwong WJ, Jhingran P (2000) Validity and reliability of the migraine-specific quality of life questionnaire (MSQ version 2.1). Headache 40:204–215PubMedCrossRef
15.
Zurück zum Zitat Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD (1995) Validation of a new quality of life questionnaire for acute migraine headache. Headache 35:330–337PubMedCrossRef Santanello NC, Hartmaier SL, Epstein RS, Silberstein SD (1995) Validation of a new quality of life questionnaire for acute migraine headache. Headache 35:330–337PubMedCrossRef
17.
Zurück zum Zitat Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:1–96CrossRef Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J (1999) Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 19:1–96CrossRef
18.
Zurück zum Zitat World Health Organization (2001) The international classification of functioning, disability and health-ICF. WHO, Geneva World Health Organization (2001) The international classification of functioning, disability and health-ICF. WHO, Geneva
19.
Zurück zum Zitat Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Del Río MS, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054–1062PubMedCrossRef Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, Ertas M, Lanteri-Minet M, Reuter U, Del Río MS, Schoenen J, Schwalen S, van Oene J, TOPMAT-MIG-303 Investigators Group (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054–1062PubMedCrossRef
20.
Zurück zum Zitat Fuh JL, Wang SJ (2006) Comparison of Short Form-36 and migraine disability assessment questionnaire in patients with migraine. Clin J Pain 22:564–568PubMedCrossRef Fuh JL, Wang SJ (2006) Comparison of Short Form-36 and migraine disability assessment questionnaire in patients with migraine. Clin J Pain 22:564–568PubMedCrossRef
21.
Zurück zum Zitat D’Amico D, Usai S, Solari A, Grazzi L, Leone M, Rigamonti A, Bussone G (2003) Relationship between disability and quality of life in migraine. In: Olesen J, Steiner TS, Lipton RB (eds) Reducing the burden of headache. Oxford University Press, New York, pp 75–78 D’Amico D, Usai S, Solari A, Grazzi L, Leone M, Rigamonti A, Bussone G (2003) Relationship between disability and quality of life in migraine. In: Olesen J, Steiner TS, Lipton RB (eds) Reducing the burden of headache. Oxford University Press, New York, pp 75–78
22.
Zurück zum Zitat Raggi A, Leonardi M, Ajovalasit D, D’Amico D, Bussone G (2010) Disability and functional profiles of patients with migraine measured with ICF classification. Int J Rehabil Res 32:225–231 Raggi A, Leonardi M, Ajovalasit D, D’Amico D, Bussone G (2010) Disability and functional profiles of patients with migraine measured with ICF classification. Int J Rehabil Res 32:225–231
23.
Zurück zum Zitat Ustun TB (1999) WHO-DAS II field trials report 1998. WHO, Geneva Ustun TB (1999) WHO-DAS II field trials report 1998. WHO, Geneva
24.
Zurück zum Zitat Cankurtaran ES, Ulug B, Saygi S, Tiryaki A, Akalan N (2005) Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy. Epilepsy Behav 7:116–122PubMedCrossRef Cankurtaran ES, Ulug B, Saygi S, Tiryaki A, Akalan N (2005) Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy. Epilepsy Behav 7:116–122PubMedCrossRef
25.
Zurück zum Zitat Martinuzzi A, Liava A, Trevisi E, Frare M, Tonon C, Malucelli E, Manners D, Kemp GJ, Testa C, Barbiroli B, Lodi R (2008) Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle’s disease. Muscle Nerve 37:350–357PubMedCrossRef Martinuzzi A, Liava A, Trevisi E, Frare M, Tonon C, Malucelli E, Manners D, Kemp GJ, Testa C, Barbiroli B, Lodi R (2008) Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle’s disease. Muscle Nerve 37:350–357PubMedCrossRef
26.
Zurück zum Zitat Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 257:98–102PubMedCrossRef Leonardi M, Raggi A, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study. J Neurol 257:98–102PubMedCrossRef
27.
Zurück zum Zitat Raggi A, Leonardi M, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis. Neurol Sci 31:41–45PubMedCrossRef Raggi A, Leonardi M, Antozzi C, Confalonieri P, Maggi L, Cornelio F, Mantegazza R (2010) Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis. Neurol Sci 31:41–45PubMedCrossRef
28.
Zurück zum Zitat Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24:S1–S160 Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24:S1–S160
29.
Zurück zum Zitat D’Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L, Leone M, Puca FM, Bussone G (2001) The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 21:947–952PubMedCrossRef D’Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L, Leone M, Puca FM, Bussone G (2001) The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 21:947–952PubMedCrossRef
30.
Zurück zum Zitat Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation. Disabil Rehabil 31:553–564PubMedCrossRef Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation. Disabil Rehabil 31:553–564PubMedCrossRef
31.
Zurück zum Zitat Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036PubMedCrossRef Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036PubMedCrossRef
32.
Zurück zum Zitat Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994PubMed Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J (1999) An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 53:988–994PubMed
33.
Zurück zum Zitat Silberstein SD, Loder E, Forde G, Papadopulos G, Fairclough D, Greenberg S (2006) The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin 22:1021–1029PubMedCrossRef Silberstein SD, Loder E, Forde G, Papadopulos G, Fairclough D, Greenberg S (2006) The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin 22:1021–1029PubMedCrossRef
34.
Zurück zum Zitat Lipton RB, Bigal ME, Stewart WF (2005) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology 65:S50–S58PubMedCrossRef Lipton RB, Bigal ME, Stewart WF (2005) Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology 65:S50–S58PubMedCrossRef
Metadaten
Titel
Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life
verfasst von
Alberto Raggi
Matilde Leonardi
Gennaro Bussone
Domenico D’Amico
Publikationsdatum
01.06.2011
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 3/2011
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-010-0466-3

Weitere Artikel der Ausgabe 3/2011

Neurological Sciences 3/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.